DrugPatentWatch Database Preview
Details for Biologics License Application: 125103
» See Plans and Pricing
Summary for BLA: 125103
| Tradename: | KEPIVANCE |
| Applicant: | Biovitrum Ab |
| Ingredient: | palifermin |
| Patents: | 51 |
| Approval Date: | Dec 15, 2004 |
| Suppliers: see list | 1 |
Pharmacology for BLA: 125103
| Ingredient-type | Fibroblast Growth Factor 7 |
| Drug Class | Mucocutaneous Epithelial Cell Growth Factor |
| Physiological Effect | Increased Epithelial Proliferation |
US Patents for BLA: 125103
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | ChemoCentryx, Inc. (Mountain View, CA) | 2036-06-13 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | Innovation Pharmaceuticals Inc. (Beverly, MA) | 2031-05-16 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | ChemoCentryx, Inc. (Mountain View, CA) | 2036-04-04 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | 2031-04-05 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | ChemoCentryx, Inc. (Mountain View, CA) | 2036-06-13 | RX | search | |
| Biovitrum Ab | KEPIVANCE | palifermin | INJECTABLE; INJECTION | 125103 | 001 | 2004-12-15 | Start Trial | The Charlotte-Mecklenburg Hospital Authority (Charlotte, NC) | 2038-02-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
